| Product Code: ETC5243869 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, New Zealand saw a diverse range of antibiotic imports with top exporting countries including Australia, Italy, USA, Metropolitan France, and India. The market remained moderately concentrated with a low Herfindahl-Hirschman Index (HHI) in 2024, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 24.16%, although there was a slight decline in growth rate from 2023 to 2024 at -3.31%. This data suggests a steady demand for antibiotics in New Zealand with a mix of suppliers contributing to the market`s growth.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Antibiotic Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Antibiotic Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Antibiotic Market - Industry Life Cycle |
3.4 New Zealand Antibiotic Market - Porter's Five Forces |
3.5 New Zealand Antibiotic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 New Zealand Antibiotic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 New Zealand Antibiotic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 New Zealand Antibiotic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Antibiotic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of infectious diseases in New Zealand |
4.2.2 Growing awareness about antibiotic resistance and the need for appropriate antibiotic use |
4.2.3 Technological advancements in antibiotic development and manufacturing |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies governing the use of antibiotics |
4.3.2 Rising concerns about the environmental impact of antibiotic use |
4.3.3 Competition from alternative treatments such as probiotics and natural remedies |
5 New Zealand Antibiotic Market Trends |
6 New Zealand Antibiotic Market Segmentations |
6.1 New Zealand Antibiotic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Antibiotic Market Revenues & Volume, By Penicillin, 2021-2031F |
6.1.3 New Zealand Antibiotic Market Revenues & Volume, By Cephalosporin, 2021-2031F |
6.1.4 New Zealand Antibiotic Market Revenues & Volume, By Aminoglycosides, 2021-2031F |
6.1.5 New Zealand Antibiotic Market Revenues & Volume, By Tetracycline, 2021-2031F |
6.1.6 New Zealand Antibiotic Market Revenues & Volume, By Macrolides, 2021-2031F |
6.1.7 New Zealand Antibiotic Market Revenues & Volume, By Fluoroquinolones, 2021-2031F |
6.1.9 New Zealand Antibiotic Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 New Zealand Antibiotic Market Revenues & Volume, By Others, 2021-2031F |
6.2 New Zealand Antibiotic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Antibiotic Market Revenues & Volume, By Skin Infections, 2021-2031F |
6.2.3 New Zealand Antibiotic Market Revenues & Volume, By Respiratory Infections, 2021-2031F |
6.2.4 New Zealand Antibiotic Market Revenues & Volume, By Urinary Tract Infections, 2021-2031F |
6.2.5 New Zealand Antibiotic Market Revenues & Volume, By Septicemia, 2021-2031F |
6.2.6 New Zealand Antibiotic Market Revenues & Volume, By Ear Infection, 2021-2031F |
6.2.7 New Zealand Antibiotic Market Revenues & Volume, By Gastrointestinal Infections, 2021-2031F |
6.3 New Zealand Antibiotic Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Antibiotic Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 New Zealand Antibiotic Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 New Zealand Antibiotic Market Revenues & Volume, By Others, 2021-2031F |
6.4 New Zealand Antibiotic Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Antibiotic Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.4.3 New Zealand Antibiotic Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.4.4 New Zealand Antibiotic Market Revenues & Volume, By Online Pharmacy, 2021-2031F |
7 New Zealand Antibiotic Market Import-Export Trade Statistics |
7.1 New Zealand Antibiotic Market Export to Major Countries |
7.2 New Zealand Antibiotic Market Imports from Major Countries |
8 New Zealand Antibiotic Market Key Performance Indicators |
8.1 Percentage of antibiotic prescriptions aligned with guidelines for appropriate use |
8.2 Investment in research and development for novel antibiotics |
8.3 Rate of antibiotic-resistant infections in New Zealand population |
9 New Zealand Antibiotic Market - Opportunity Assessment |
9.1 New Zealand Antibiotic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 New Zealand Antibiotic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 New Zealand Antibiotic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 New Zealand Antibiotic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Antibiotic Market - Competitive Landscape |
10.1 New Zealand Antibiotic Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Antibiotic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |